Paper34869683
Adiponectin Related Vascular and Cardiac Benefits in Obesity: Is There a Role for an Epigenetically Regulated Mechanism?
Fontanella RA and 7 others. Front Cardiovasc Med, 2021. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Adiponectin Related Vascular and Cardiac Benefits in Obesity: Is There a Role for an Epigenetically Regulated Mechanism? Papers, record 34869683. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34869683
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Adiponectin Related Vascular and Cardiac Benefits in Obesity: Is There a Role for an Epigenetically Regulated Mechanism?
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30915894 | DNA methylation markers in obesity, metabolic syndrome, and weight loss. | Epigenetics | 2019 | https://conductscience.org/library/papers/30915894 | PubMed |
| 2 | 30246793 | Inflammatory Cytokines and SIRT1 Levels in Subcutaneous Abdominal Fat: Relationship With Cardiac Performance in Overweight Pre-diabetics Patients. | Front Physiol | 2018 | https://conductscience.org/library/papers/30246793 | PubMed |
| 3 | 17343838 | Adiponectin as an anti-inflammatory factor. | Clin Chim Acta | 2007 | https://conductscience.org/library/papers/17343838 | PubMed |
| 4 | 33298413 | 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. | Diabetes Care | 2021 | https://conductscience.org/library/papers/33298413 | PubMed |
| 5 | 33712063 | miR-21: a non-specific biomarker of all maladies. | Biomark Res | 2021 | https://conductscience.org/library/papers/33712063 | PubMed |
| 6 | 21427505 | Inflammation and the development of atherosclerosis. | J Atheroscler Thromb | 2011 | https://conductscience.org/library/papers/21427505 | PubMed |
| 7 | 23015294 | MicroRNAs regulated by adiponectin as novel targets for controlling adipose tissue inflammation. | Endocrinology | 2012 | https://conductscience.org/library/papers/23015294 | PubMed |
| 8 | 29084944 | DNA-Methylation and Body Composition in Preschool Children: Epigenome-Wide-Analysis in the European Childhood Obesity Project (CHOP)-Study. | Sci Rep | 2017 | https://conductscience.org/library/papers/29084944 | PubMed |
| 9 | 10604883 | Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. | Circulation | 1999 | https://conductscience.org/library/papers/10604883 | PubMed |
| 10 | 23644594 | A genome-wide methylation study on obesity: differential variability and differential methylation. | Epigenetics | 2013 | https://conductscience.org/library/papers/23644594 | PubMed |
| 11 | 28627656 | Adipokines and free fatty acids regulate insulin sensitivity by increasing microRNA-21 expression in human mature adipocytes. | Mol Med Rep | 2017 | https://conductscience.org/library/papers/28627656 | PubMed |
| 12 | 23597671 | Globular adiponectin modulates expression of programmed cell death 4 and miR-21 in RAW 264.7 macrophages through the MAPK/NF-κB pathway. | FEBS Lett | 2013 | https://conductscience.org/library/papers/23597671 | PubMed |
| 13 | 24630777 | DNA methylation and body-mass index: a genome-wide analysis. | Lancet | 2014 | https://conductscience.org/library/papers/24630777 | PubMed |
| 14 | 24455420 | Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. | ISRN Inflamm | 2013 | https://conductscience.org/library/papers/24455420 | PubMed |
| 15 | 23469214 | Feedback regulations of miR-21 and MAPKs via Pdcd4 and Spry1 are involved in arsenite-induced cell malignant transformation. | PLoS One | 2013 | https://conductscience.org/library/papers/23469214 | PubMed |
| 16 | 33090591 | Incretin drugs effect on epigenetic machinery: New potential therapeutic implications in preventing vascular diabetic complications. | FASEB J | 2020 | https://conductscience.org/library/papers/33090591 | PubMed |
| 17 | 26337909 | NF-κB: Regulation by Methylation. | Cancer Res | 2015 | https://conductscience.org/library/papers/26337909 | PubMed |
| 18 | 31974244 | Tracking complex mixtures of chemicals in our changing environment. | Science | 2020 | https://conductscience.org/library/papers/31974244 | PubMed |
| 19 | 21381024 | MicroRNA 21 regulates the proliferation of human adipose tissue-derived mesenchymal stem cells and high-fat diet-induced obesity alters microRNA 21 expression in white adipose tissues. | J Cell Physiol | 2012 | https://conductscience.org/library/papers/21381024 | PubMed |
| 20 | 1401629 | Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. | J Am Coll Cardiol | 1992 | https://conductscience.org/library/papers/1401629 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42544277 | Incretin-based therapies and PPARγ agonists as regulators of adipokines-Nrf2 axis in diabetic cardiovascular disease. | Glob Cardiol Sci Pract | 2026 | https://conductscience.org/library/papers/42544277 | PubMed |
| 40013194 | The Interplay Between Adipokines and Body Composition in Obesity and Metabolic Diseases. | Cureus | 2025 | https://conductscience.org/library/papers/40013194 | PubMed |
| 38845616 | Post-stroke cognitive impairment: exploring molecular mechanisms and omics biomarkers for early identification and intervention. | Front Mol Neurosci | 2024 | https://conductscience.org/library/papers/38845616 | PubMed |
| 38405061 | Epigenetic modifications in obesity-associated diseases. | MedComm (2020) | 2024 | https://conductscience.org/library/papers/38405061 | PubMed |
| 37608837 | Elucidating the primary mechanisms of high-intensity interval training for improved cardiac fitness in obesity. | Front Physiol | 2023 | https://conductscience.org/library/papers/37608837 | PubMed |
| 36732760 | Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors. | Cardiovasc Diabetol | 2023 | https://conductscience.org/library/papers/36732760 | PubMed |
| 36250025 | Long non-coding RNA NBAT1, TUG1, miRNA-335, and miRNA-21 as potential biomarkers for acute ischemic stroke and their possible correlation to thyroid hormones. | Front Mol Biosci | 2022 | https://conductscience.org/library/papers/36250025 | PubMed |
| 35788967 | Cardiovascular Disease Risk Reduction and Body Mass Index. | Curr Hypertens Rep | 2022 | https://conductscience.org/library/papers/35788967 | PubMed |
| 35682868 | Organokines in Rheumatoid Arthritis: A Critical Review. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35682868 | PubMed |
| 35360165 | Dual Roles of Coconut Oil and Its Major Component Lauric Acid on Redox Nexus: Focus on Cytoprotection and Cancer Cell Death. | Front Neurosci | 2022 | https://conductscience.org/library/papers/35360165 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34869683
GET https://conductscience.org/api/papers/v1/34869683/references?page=2